Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27595248 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28457844 | 0.95 | — | — | |
| SCHEMBL72672 | 0.94 | — | — | |
| Methane SCHEMBL21834863 | 0.89 | — | — | |
| Ammonia Solution, Strong SCHEMBL18670575 | 0.89 | — | — | |
| Ammonia Solution, Strong SCHEMBL8054013 | 0.89 | — | — | |
| Hypochlorous Acid SCHEMBL11421786 | 0.80 | — | — | |
| SCHEMBL27314965 | 0.77 | TSHR (0.38) | — | |
| Hydrochloric Acid SCHEMBL9339715 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL2774816 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250249016-A1 | IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS | Red Mountain Med Spa, LLC (US) | 2025-08-07 | — | — | US | claimed |
| US-20240075043-A1 | IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS | Red Mountain Med Spa, LLC (US) | 2024-03-07 | — | — | US | claimed |
| US-11896598-B2 | Appetite suppressant compositions and methods thereof | Red Mountain Med Spa, LLC (US) | 2024-02-13 | — | — | US | claimed |
| US-20220249505-A1 | APPETITE SUPPRESSANT COMPOSITIONS AND METHODS THEREOF | RED MOUNTAIN HOLDINGS, LLC (US) | 2022-08-11 | — | — | US | claimed |
| US-20220170019-A1 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBSESITY | UNIVERSIDAD DE MÁLAGA (ES) | 2022-06-02 | — | — | US | claimed |
| EP-3960859-A1 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBSESITY | Servicio Andaluz De Salud (ES) | 2022-03-02 | — | — | EP | claimed |
| WO-2020165482-A1 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBSESITY | SERVICIO ANDALUZ DE SALUD (ES) | 2020-08-20 | — | — | WO | claimed |
| US-8679535-B2 | Sustained release matrix systems for highly soluble drugs | ENDO PHARMACEUTICALS INC. (US) | 2014-03-25 | — | — | US | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| EP-1594517-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | Microbia, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20050020811-A1 | Methods and compositions for the treatment of gastrointestinal disorders | WELLS FARGO BANK, NATIONAL ASSOCIATION | 2005-01-27 | — | — | US | claimed |
| US-20040266989-A1 | Methods and compositions for the treatment of gastrointestinal disorders | MICROBIA, INC. | 2004-12-30 | — | — | US | claimed |
| WO-2004069165-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | MICROBIA, INC. (US) | 2004-08-19 | — | — | WO | claimed |
| US-6153223-A | PREMIXING A CARRIER AND AN AQUEOUS SOLUTION OF AN ACID AND DRYING; MIXING A STABILIZING AMOUNT OF THE ACIDIC CARRIER WITH A PHARMACEUTICAL AGENT UNSTABLE AT A PH >3.5; FORMING A STABILIZING MICROENVIRONMENT AROUND THE PHARMACEUTICAL AGENT | WATSON PHARMACEUTICALS, INC. (US) | 2000-11-28 | — | — | US | claimed |
| WO-1999062499-A1 | STABILIZED PHARMACEUTICAL COMPOSITIONS | WATSON PHARMACEUTICALS, INC. (US) | 1999-12-09 | — | — | WO | claimed |
| EP-0095123-B1 | SUSTAINED RELEASE DIETHYLPROPION COMPOSITIONS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1987-09-02 | — | — | EP | claimed |
| US-4421736-A | ANOREXIGENIC AGENTS | MERREL DOW PHARMACEUTICALS INC. (US) | 1983-12-20 | — | — | US | claimed |
| EP-0095123-A2 | Sustained release diethylpropion compositions | MERRELL DOW PHARMACEUTICALS INC. (US) | 1983-11-30 | — | — | EP | claimed |
| US-3968245-A | Sympathomimetic topical and percutaneous administration with halogenated promoters | ALZA CORPORATION (US) | 1976-07-06 | — | — | US | claimed |